Metraipolis › archive › dc_97cce99ffe95

Tafenoquine: A Breakthrough Option for Babesiosis Treatment — Europe PMC PMID:42188870

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42188870
DOI: 10.3390/tropicalmed11050141
License (as archived): solo-consultazione
Archived: 2026-11-01T15:17:40.315Z
SHA-256 of the archived text: 0d2d5c3c033176aeb2d67178e13f5bb2a576e1bdd954b04eb82855c004a486a5
Stable URL of this page: https://metraipolis.com/documento/dc_97cce99ffe95

How to cite

Tafenoquine: A Breakthrough Option for Babesiosis Treatment — Europe PMC PMID:42188870 — Europe PMC (en), https://europepmc.org/article/MED/42188870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97cce99ffe95 (Metraipolis archive dc_97cce99ffe95, sha256 0d2d5c3c033176aeb2d67178e13f5bb2a576e1bdd954b04eb82855c004a486a5)

BibTeX

@misc{dc97cce99ffe95,
  title = {Tafenoquine: A Breakthrough Option for Babesiosis Treatment — Europe PMC PMID:42188870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97cce99ffe95; sha256 0d2d5c3c033176aeb2d67178e13f5bb2a576e1bdd954b04eb82855c004a486a5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188870. Agents can read the archived copy with the MCP tool read_document.